CLINICAL_TRIALS trial_result · 2024-05-28

Clinical Trial Update: A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy [Phase 1]

Phase 1 clinical trial update for C-CAR066 in relapsed/refractory B-cell lymphoma patients who previously received CD19 CAR-T therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine | Conditions: B Cell Lymphoma | Phase 1 | Status: COMPLETED